McDermott Will & Emery advised Corteria Pharmaceuticals on the deal.Corteria Pharmaceuticals, a French biotechnology company specializing in the development of interceptive therapies for heart failure sub-…
Corteria Pharmaceuticals’ €12 Million Financing Round
